《本地樓市》恆地(00012.HK)Belgravia Place首批價單148伙 折實入場費316.8萬
恆地(00012.HK)公布長沙灣巴域街項目Belgravia Place首張價單,涉及148伙,折實平均呎價15,902元。開放式單位入場費316.8萬元起。
首張價單戶型涵蓋開放式至三房,包括6伙開放式、66伙一房單位、66伙兩房單位、10伙三房單位。
恆基物業代理營業(一)部總經理林達民形容,首張價單定價為「釋放潛能價」,並指心目中項目合理定價約呎價1.7萬元至1.8萬元,希望第一張價單以吸引價格吸引更多買家。
他指,項目明日對外開放示範單位及開放認購登記,最快下周末開售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.